Redwood Scientific Technologies Inc. Stock Analysis RSCI
Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company is headquartered in Albany, New York. The company went IPO on 2008-03-12. RST utilizes Patent-pending, sublingual strip delivery technology that enhances bioavailability. The main product, Prolongz, is designed to treat premature ejaculation in men. Prolongz has been registered with the FDA #079526408, allowing Redwood to elevate ourselves from competitors. Redwoods Prolongz is on course to establish ourselves as the industry leader for the adult male sexual performance dysfunction market through our membership (subscription) model. The firm is aggressively expanding our customer population through heavy investments in national cable television commercials and infomercials which also drives consumer awareness and retail sales. Source: Crunchbase
Read More Redwood Scientific Technologies Inc (RSCI) Chart
Key Statistics of Redwood Scientific Technologies Inc (RSCI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
192.00P/E Ratio (TTM)
-52 Week Range
Market Cap
2.27MAvg. Volume
104.50Dividend Yield
-Financial Metrics & Statements of Redwood Scientific Technologies Inc (RSCI)
FAQ's for Redwood Scientific Technologies Inc (RSCI)
- According to Musaffa’s Shariah screening methodology, Redwood Scientific Technologies Inc (RSCI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.